The Profile Group Limited has been acquired by Centaur Media plc.
The shareholders of The Profile Group Limited (Profile) have sold the company to Centaur Media plc., the leading UK-based business information, publishing and events group, for US$12.5 million.
Profile provides up-to-date news and information to the media and marketing communities. The group has successfully migrated to digital delivery of its products over the past three years which was a major factor in the successful sale of the business. Fashion Monitor, the fashion information service used by all the leading media in the UK, has been sold as part of the sale of The Profile Group.
Centaur Media plc. operates through four segments: marketing, financial services, home interest and professional.
Oaklins Cavendish, based in the UK, advised the seller in this transaction.


Talk to the deal team
Related deals
BodhiCedric has acquired Network Media from Jellysmack
The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.
Learn moreCustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more